LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,000 | -94.3% | 151 | -93.9% | 0.00% | -100.0% |
| Q4 2018 | $334,000 | -38.5% | 2,461 | +24.5% | 0.00% | -33.3% |
| Q3 2018 | $543,000 | -6.5% | 1,976 | -29.5% | 0.01% | -14.3% |
| Q2 2018 | $581,000 | +11.3% | 2,802 | -11.2% | 0.01% | +16.7% |
| Q1 2018 | $522,000 | +13.7% | 3,157 | -6.0% | 0.01% | +20.0% |
| Q4 2017 | $459,000 | -9.8% | 3,358 | -10.2% | 0.01% | -16.7% |
| Q3 2017 | $509,000 | – | 3,741 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |